Search

Author/Creator Cervantes, A

2. 1654PSoft tissue sarcomas (STS) in elder patients: No impact of age on overall survival (OS) in an unselected cohort. (23rd October 2018)

Authors:
Perez Fidalgo, J A; Lopez, A; Gambardella, V; Navarro, S; Iranzo, A; Diaz Fernandez, N; Tolosa, P; Silvestre, A; Iriarte Moncho, E; Garcia Mora, M C; De la Paz, A; Soler, J J; Cervantes, A
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 28PCNAs concordance between CRC-PDOs and the original tissue reveals relevant oncogenic pathways alterations. (7th November 2019)

Authors:
Papaccio, F; Valiente, F G; Gutierrez-Bravo, M F; Cabeza-Segura, M; Gambardella, V; Huerta, M D S; Martinez-Ciarpaglini, C; Alfaro-Cervello, C; Rentero-Garrido, P; Zúñiga-Trejos, S; Rosello Keranen, S; Fleitas, T; Tarazona, N; Roda Perez, D; Cervantes, A; Castillo, J
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 7
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 438PSafety and efficacy of the PD-1 inhibitor ABBV-181 in patients with advanced solid tumors: Preliminary phase I results from study M15-891. (23rd October 2018)

Authors:
Powderly, J; Cassier, P A; Cervantes, A; Gao, B; Gazzah, A; Italiano, A; Lin, C-C; Luke, J J; Moreno, V; Peltola, K; Rasco, D; Spira, A I; Tanner, M M E; Tosi, D; Afar, D; Englert, S; Parikh, A; Reddy, A; Vosganian, G; Tolcher, A W
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 463PReal-world dosing of regorafenib (REG) in metastatic colorectal cancer (mCRC): Final results from the prospective, observational CORRELATE study. (23rd October 2018)

Authors:
O'Connor, J M; Ducreux, M; Petersen, L N; Öhler, L; Bergamo, F; Metges, J-P; de Groot, J W; Wang, J-Y; García Paredes, B; Dochy, E; Fiala-Buskies, S; Cervantes, A; Falcone, A
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 522OMutation tracking in circulating tumour DNA (ctDNA) detects minimal residual disease (MRD) in patients with localized colorectal cancer (CRC) and identifies those at high risk of recurrence regardless of stage, lack of CDX2 expression and CMS subtype. (1st October 2019)

Authors:
Llavero, N Tarazona; Gimeno-Valiente, F; Gambardella, V; Huerta, M; Keranen, S Rosello; Bruixola, G; Fontana, E; Ciarpaglini, C Martinez; Zuñiga, S; Rentero, P; Fleitas, T; Papaccio, F; Moro, D; Pla, V; Nyamundanda, G; Castillo, J; Sadanadam, A; Espí, A; Roda, D; Cervantes, A
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. 53PZNF518B as a transcriptional factor involved in colorectal cancer progression through the epithelial to mesenchymal transition. (7th November 2019)

Authors:
Valiente, F G; Tarazona, N; Gambardella, V; Riffo-Campos, Á; Papaccio, F; Cabeza-Segura, M; López-Rodas, G; Cervantes, A; Franco, L; Castillo, J
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 7
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. 665PNRF2 activation via PI3K/AKT/mTOR/RPS6 causes resistance to anti-HER2 agents among HER2 amplified gastric cancer. (23rd October 2018)

Authors:
Gambardella, V; Gimeno-Valiente, F; Tarazona, N; Fleitas Kanonnikoff, T; Tolosa, P; Belda Moscardò, M; Garcia-Mico, B; Huerta, M; Roselló, S; Roda, D; Cervantes, A; Castillo, J
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. 777TiPA phase III, double-blind, randomized study of pamiparib versus placebo as maintenance therapy in patients with inoperable, locally advanced, or metastatic gastric cancer that responded to platinum-based first-line chemotherapy. (23rd October 2018)

Authors:
Ciardiello, F; Bang, Y-J; Bendell, J; Cervantes, A; Brachmann, R; Zhang, K; Raponi, M; Farin, H; Shen, L
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. 86P A novel ImmunoScore, based on clinical and blood biomarkers, as prognostic model for immunotherapy in NSCLC. (15th December 2019)

Authors:
Viscardi, G; Sparano, F; Di Liello, R; Casal, G Alonso; Ferreres, R Borras; Bruixola, G; Gambardella, V; Zanaletti, N; Iacovino, M L; Corte, C M Della; Papaccio, F; Fasano, M; Ciardiello, F; Cervantes, A; Morgillo, F; Martorell, P Martin; Molla, M A Insa
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 11
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗